Positive FDA cell & gene therapy roundtable but emphasis on speedy access has risks
I had high expectations when I saw the list of speakers for an FDA Cell & Gene Therapy Roundtable held today. Admittedly, earlier when I had seen the meeting announced and no speakers were listed, I wondered how it might go. Would it be like the earlier RFK Jr. regenerative medicine roundtable? That private meeting […]
Positive FDA cell & gene therapy roundtable but emphasis on speedy access has risks Read More »